Global Hyaluronic Acid (HA) Market 2022-2028

October 2022 | 76 pages | ID: G0337B1F46D7EN
Gen Consulting Company

Abstracts

Hyaluronic acid, also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. According to Gen Consulting Company, the global hyaluronic acid market is set to achieve an incremental growth of USD 4 billion, acelerating at a CAGR of almost 6.7% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global hyaluronic acid market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the hyaluronic acid industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for hyaluronic acid can be segmented by application: dermal fillers, ophthalmic, osteoarthritis (single injection, three injection, and five injection), vesicoureteral reflux (VUR). Hyaluronic acid market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW).

By application:

• dermal fillers
• ophthalmic
• osteoarthritis (single injection, three injection, and five injection)
• vesicoureteral reflux (VUR)

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading hyaluronic acid market vendors that include Allergan plc, Anika Therapeutics, Inc., Bloomage Biotechnology Corp., Ltd., Ferring B.V., Galderma S.A., LG Chem Ltd., Lifecore Biomedical, Inc., Maruha Nichiro Corporation, Sanofi S.A., Seikagaku Corporation, Shiseido Co., Ltd., Smith & Nephew plc, Zimmer Biomet Holdings, Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global hyaluronic acid market.
• To classify and forecast the global hyaluronic acid market based on application, region.
• To identify drivers and challenges for the global hyaluronic acid market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global hyaluronic acid market.
• To identify and analyze the profile of leading players operating in the global hyaluronic acid market.

Why Choose This Report

• Gain a reliable outlook of the global hyaluronic acid market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY APPLICATION
Dermal fillers
Ophthalmic
Osteoarthritis (single injection, three injection, and five injection)
Vesicoureteral reflux (VUR)
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 7. KEY COMPANIES
Allergan plc
Anika Therapeutics, Inc.
Bloomage Biotechnology Corp., Ltd.
Ferring B.V.
Galderma S.A.
LG Chem Ltd.
Lifecore Biomedical, Inc.
Maruha Nichiro Corporation
Sanofi S.A.
Seikagaku Corporation
Shiseido Co., Ltd.
Smith & Nephew plc
Zimmer Biomet Holdings, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER